Sign In
Buy OGN
$13.40
+0.0200 (+0.149%)
At Close: Jun 03, 2026
NEW YORK , June 27, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Organon & Co. ("Organon" or the "Company") (NYSE: OGN). Such investors are advis
OGN LAWSUIT ALERT: Levi & Korsinsky Notifies Organon & Co. Investors of a Class Action Lawsuit and Upcoming Deadline
09:00am, Friday, 27'th Jun 2025
NEW YORK , June 27, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Organon & Co. ("Organon" or the "Company") (NYSE: OGN) of a class action securities lawsuit. CLASS DEFINITION: The
OGN Investors Have the Opportunity to Lead the Organon Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
08:19pm, Thursday, 26'th Jun 2025
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Organon To Contact Him Directly To Discuss Their Options If you
OGN Investors Have Opportunity to Lead Organon & Co. Securities Fraud Lawsuit
05:02pm, Thursday, 26'th Jun 2025
NEW YORK , June 26, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Organon & Co. (NYSE: OGN) between October 31, 2024 and April 30,
NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Organon & Co. (NYSE: OGN).
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 22, 2025 in Organon Lawsuit - OGN
09:00am, Thursday, 26'th Jun 2025
NEW YORK , June 26, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Organon & Co. (NYSE: OGN). Shareholders who purchased shares of OGN during the class period l
OGN SECURITIES: Lose Money on Organon & Co. (NYSE:OGN)? Contact BFA Law about the Pending Securities Fraud Class Action
08:36am, Thursday, 26'th Jun 2025
NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Organon & Co. (NYSE: OGN) and certain of the Company'
NEW ORLEANS, June 25, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until July 22, 2025 to file lead plaintiff applications in a securi
NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Organon & Co. (NYSE: OGN) between October 31, 2024 and April 30
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
10:00am, Wednesday, 25'th Jun 2025
Organon (OGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Organon & Co. (OGN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
09:00am, Wednesday, 25'th Jun 2025
BENSALEM, Pa. , June 25, 2025 /PRNewswire/ -- The Law Offices of Howard G.
NEW YORK and NEW ORLEANS, June 24, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they h
Investors who lost money on Organon & Co.(OGN) should contact Levi & Korsinsky about pending Class Action - OGN
04:16pm, Tuesday, 24'th Jun 2025
NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Organon & Co. ("Organon" or the "Company") (NYSE: OGN) of a class action securities lawsuit.
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon
11:32am, Tuesday, 24'th Jun 2025
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Organon To Contact Him Directly To Discuss Their Options
Organon & Co. (OGN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
11:00am, Tuesday, 24'th Jun 2025
LOS ANGELES , June 24, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Organon & Co. ("Organon" or the "Company") (NYSE: OGN) have opportunity to
